A new innovate device for treatment of hemorrhoids
Mucopexy: A Proven Technique
PexyEazy® is based on mucopexy, a well-established surgical technique first described by PJ.Gupta in 2008 and F. Pakravan in 2009. Mucopexy involves lifting the mucosal layer above hemorrhoids to restore normal positioning, thereby improving venous drainage, and reducing swelling. While often combined with other treatments like THD, DGHAL, and laser therapy, mucopexy alone has proven just as effective, but faster and simpler. PexyEazy® elevates this method with its semi-automatic suture application, making it not only efficient and user-friendly but also easy to master, ensuring a swift learning curve for surgeons.
Cost Efficiency Enhanced
PexyEazy® offers a revolutionary approach to treating grade II and III hemorrhoids. This innovative procedure, completed in under 10 minutes, eliminates the need for general anesthesia, leading to a remarkable cost reduction of up to 70%. This significant saving stems from PexyEazy®’s design for office-based procedures, bypassing the expensive operating room fees that can range from $25 to $35 per minute in the U.S.
Potentially improved outcome
PexyEazy® ensures improved precision in suture placement, with predefined depth. The device precisely places straight sutures through the tissue, minimizing tissue stretching during bowel movements. In contrast, manual suturing typically involves a spiral or serpentine pattern, which uses more suture material and is more likely to lose its lifting effect. PexyEazy®’s innovative approach is set to greatly enhance mucopexy procedure outcomes.
Consistency In Surgery
PexyEazy® ensures uniformity in suture placement, with predefined depth, width, and length settings. This consistency contrasts sharply with the variability of manual suturing, where depth, width, and length can differ, leading to inconsistent results. PexyEazy®’s precision is expected to yield better outcomes and lower recurrence rates.
Sustainability
Sustainability is a core value of PexyEazy®’s design and usage. The plastic parts of the device are estimated to give rise to only 4 kg of CO2, which is comparable to a regular hamburger meal. By comparison, a standard surgical procedure under general anesthesia emits 189 kg of CO2e per surgical procedure. Even though PexyEazy® is a single-use device is it a good alternative also for sustainability reasons, since it enables surgery as an office-based procedure without general anesthesia. By transitioning to PexyEazy®, healthcare facilities can potentially reduce their carbon emissions by approximately 185kg per procedure.
Furthermore, in our sustainability efforts, we have developed a special battery pack that allows a standard AAA battery to be reused for more than 40 PexyEazy® procedures. This not only marks a significant leap towards environmental sustainability compared with competitors, but also enable surgery without requirement of complex equipment, reaching our goal to bring advanced hemorrhoidal surgery globally.
In our commitment to sustainability, we have engaged in the initial phase of the EIC Greenhouse Gas Programme.
Global Surgical Innovation
When we developed PexyEazy®, we aimed to make hemorrhoid surgery available worldwide. We prioritized a patient centered and user-friendly design and a quick, safe and straight forward procedure that saves cost and does not require complex equipment. The result is PexyEazy®, a device that enables treatment even at simple medical facilities, giving the opportunity to make advanced hemorrhoid surgery available globally.
PexyEazy® has the long-awaited potential to provide our patients with a quick and simple procedure with low pain and a good long-term result.
Johan Ungerstedt, founder of Developeration
Benefits for the Patient
PexyEazy® is redefining hemorrhoid treatment by prioritizing the patient’s comfort and well-being. No tissue is surgically removed or destroyed with heat, laser or chemicals, instead are the hemorrhoids simply lifted back to their normal position in a fast and minimal invasive way. PexyEazy® have the potential to give out patients a rapid recovery, less pain, and a faster return to normal activities.
important things you should know
Questions And Answers
PexyEazy® sets a new standard for hemorrhoid treatment, offering a minimally invasive option that delivers long-term effectiveness comparable to more invasive procedures. From clinical studies on manual mucopexy is the method shown to match the low relapse rates of traditional surgeries, but promises a less painful experience with quick recovery. PexyEazy®’s efficient 10-minute treatment not only eases the patient’s journey but also streamlines clinic flow, reducing waiting times and free up space at the operation theatre. This innovative approach leads to minimized sick leave, decreased dependence on strong painkillers, and ultimately, higher patient satisfaction.
PexyEazy® streamlines advanced hemorrhoidal surgery, reducing procedure time to under 10 minutes as an office-based intervention. This efficiency allows clinics to perform four time more procedures daily and liberate operating theatre space for urgent surgeries, such as cancer or emergency operations. In Sweden, where hospitals typically offer limited treatment options, PexyEazy® may fill the gap between simple band ligation and complex hemorrhoidectomy. The device’s user-friendly design ensures a rapid learning curve, presenting an ideal training opportunity for surgical residents.
PexyEazy® transforms hemorrhoid surgery into a quick, in-office procedure, dramatically cutting costs by up to 70% compared to traditional methods. This cost-effectiveness mirrors that of rubber band ligation, which often requires multiple sessions for lasting results, as indicated by the HubBle Study. For patients, PexyEazy® have the potential to not only shortens waiting times but also accelerates recovery and substantially reduce the duration of sick leave. Environmentally, PexyEazy® is a single-use device with a low CO2 footprint of just 4kg—far less than the 189kg typically emitted during conventional surgeries with general anesthesia. Adopting PexyEazy® could potentially reduce CO2 emissions by 185kg per operation, marking a significant step towards greener medical practices.